A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The pathophysiology of SARS-Cov-2 is characterized by inflammation, immune dysregulation, coagulopathy, and endothelial dysfunction. No single therapeutic agent can target all these pathophysiologic substrates. Moreover, the current therapies are not fully effective in reducing mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ambudhar, Sharma, Charu, Raina, Sujeet, Singh, Balraj, Dadhwal, Devendra Singh, Dogra, Vinay, Gupta, Swatantra, Bhandari, Shyam, Sood, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280682/
https://www.ncbi.nlm.nih.gov/pubmed/34266452
http://dx.doi.org/10.1186/s13063-021-05361-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280682/
https://www.ncbi.nlm.nih.gov/pubmed/34266452
http://dx.doi.org/10.1186/s13063-021-05361-y

Ejemplares similares